Giorgio Walter Canonica

Add links
From Wikipedia, the free encyclopedia
Giorgio Walter Canonica
Giorgio Walter Canonica
Born(1947-10-25)October 25, 1947
CitizenshipItalian
Alma mater University of Genoa, Milan, Italy
Scientific career
InstitutionsMedical University of South Carolina
Uppsala University
Humanitas University, Milan
World Allergy Organization
Global Asthma Association (INTERASMA)

Giorgio Walter Canonica (Born October 25, 1947) is an Italian allergist, pulmonologist and professor of Respiratory Medicine at Humanitas University, Milan, Italy and Director Personalized Medicine Asthma & Allergy Center at Humanitas Research Hospital IRCCS-Milano Italy since December 2016.[1] He is known for his research work related to innovative treatment strategies for allergic diseases which includes biological response modifier in form of targeted immunotherapy with primary emphasis on sublingual immunotherapy (SLIT).[2] He has served as Secretary General and President elect of World Allergy Organisation for six consecutive years and has served as president of the same organization during 2007–09. He is also the vice-president of INTERASMA.[3][4]

Early life and education[edit]

Canonica received his master's degree from School of Medicine, University of Genoa during 1972. He started his career as a specialist in pulmonary disease at University of Genoa. He then moved to Florence University while keeping the primary specialization in Allergy and Clinical Immunology. Consequently, he carried out research works in clinical immunology and allergology research from University of Uppsala, Sweden and Medical University of South Carolina, Charleston, USA.[3]

Career[edit]

Canonica returned to Genoa University in 1995 and served at different positions including the full professor Internal Medicine and Pulmonary Medicine, Director of the Speciality School of Allergy and Clinical Immunology, Director of the Specialty School of Pulmonary Diseases, Chairman of the Department of Medical Specialties (University Hospital San Martino Genoa, Italy), Laurea Honoris Causa, Cluji Medical University, Romania etc..[5][6][7][8] He is also currently serving as Editor in chief of Current Opinion in Allergy and Clinical Immunology.[9]

Previously, Canonica worked as the president of World Allergy Organization (WAO), Global Asthma Association (INTERASMA),[10][11] Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)[12] and Italian Society of Respiratory Medicine (SIMeR).[13] He is presently serving as the ExCom Member of Allergic Rhinitis and its Impact on Asthma (ARIA),[14] board members of Collegium Internationale Allergologicum[15] (CIA) and Global Allergy & Asthma Excellence Network[16] (GA²LEN). He is also working as the Vice-president of Respiratory Effectiveness Group[17] (REG), Chair of the Methodology Committee (EAACI),[18] International advocate of Global Asthma InitiAtive (GINA).[19] Canonica is one of the steering committee members of Severe Asthma Network Italy registry (SANI) and member of European Academy of Sciences.[20]

Research areas[edit]

Canonica's research areas primarily include the observations of molecular events, which further includes interactivity of epithelial cells, inflammatory cells and immunocompetent cells in allergic inflammation and airway remodeling. He is also known to be involved in innovative treatment strategies for allergic diseases including biological response modifier in form of targeted immunotherapy with primary emphasis on sublingual immunotherapy (SLIT).[5]

Notable publications[edit]

  • Zuberbier, T.; Aberer, W.; Asero, R.; Abdul Latiff, A. H.; Baker, D.; Ballmer-Weber, B.; Bernstein, J. A.; Bindslev-Jensen, C.; Brzoza, Z.; Buense Bedrikow, R.; Canonica, G. W.; Church, M. K.; Craig, T.; Danilycheva, I. V.; Dressler, C.; Ensina, L. F.; Giménez-Arnau, A.; Godse, K.; Gonçalo, M.; Grattan, C.; Hebert, J.; Hide, M.; Kaplan, A.; Kapp, A.; Katelaris, C. H.; Kocatürk, E.; Kulthanan, K.; Larenas-Linnemann, D.; Leslie, T. A.; Magerl, M.; Mathelier-Fusade, P.; Meshkova, R. Y.; Metz, M.; Nast, A.; Nettis, E.; Oude-Elberink, H.; Rosumeck, S.; Saini, S. S.; Sánchez-Borges, M.; Schmid-Grendelmeier, P.; Staubach, P.; Sussman, G.; Toubi, E.; Vena, G. A.; Vestergaard, C.; Wedi, B.; Werner, R. N.; Zhao, Z.; Maurer, M. (July 2018). "The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria". Allergy. 73 (7): 1393–1414. doi:10.1111/all.13397. hdl:10230/35554. PMID 29336054.
  • Brożek, Jan L.; Bousquet, Jean; Baena-Cagnani, Carlos E.; Bonini, Sergio; Canonica, G. Walter; Casale, Thomas B.; van Wijk, Roy Gerth; Ohta, Ken; Zuberbier, Torsten; Schünemann, Holger J. (September 2010). "Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision" (PDF). Journal of Allergy and Clinical Immunology. 126 (3): 466–476. doi:10.1016/j.jaci.2010.06.047. hdl:1822/49100. PMID 20816182. S2CID 536060.
  • Canonica, G. W.; Baena-Cagnani, C. E.; Bousquet, J.; Bousquet, P. J.; Lockey, R. F.; Malling, H.-J.; Passalacqua, G.; Potter, P.; Valovirta, E. (8 February 2007). "Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce: Recommendations for immunotherapy clinical trials". Allergy. 62 (3): 317–324. doi:10.1111/j.1398-9995.2006.01312.x. PMID 17298350. S2CID 16237704.

References[edit]

  1. ^ Varricchi, Gilda; Senna, Gianenrico; Loffredo, Stefania; Bagnasco, Diego; Ferrando, Matteo; Canonica, Giorgio Walter (2017). "Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?". Frontiers in Immunology. 8: 242. doi:10.3389/fimmu.2017.00242. ISSN 1664-3224. PMC 5344894. PMID 28344579.
  2. ^ "Giorgio Walter Canonica". Hunimed. Retrieved 2020-10-13.
  3. ^ a b "Academy of Europe: Canonica Giorgio Walter". www.ae-info.org. Retrieved 2020-10-13.
  4. ^ "Expertise in Asthma: Giorgio Walter Canonica - Interasma's Chief Executive Director". GAA Interasma. Retrieved 2020-10-13.
  5. ^ a b "SRxA | Professor Giorgio Walter Canonica". www.srxa.com. Retrieved 2020-10-13.
  6. ^ "Resume - Giorgio Walter Canonica" (PDF).
  7. ^ "Academy of Europe: CV". www.ae-info.org. Retrieved 2020-10-13.
  8. ^ "Giorgio Walter Canonica - Professor of Pediatrics Allergy and Immunology, Respiratory Therapy in Genova, Liguria, Italy | eMedEvents". www.emedevents.com. Retrieved 2020-10-13.
  9. ^ "Editorial introductions". Current Opinion in Allergy and Clinical Immunology. 9 (1): vii–x. 2009. doi:10.1097/ACI.0b013e328324b654. ISSN 1528-4050.
  10. ^ "Professor Giorgio Walter Canonica". www.aminer.cn. Retrieved 2021-07-05.
  11. ^ "Expertise in Asthma: Giorgio Walter Canonica - Interasma's Chief Executive Director". GAA Interasma. Retrieved 2021-07-05.
  12. ^ Rossi, Oliviero; Massaro, Ilaria; Caminati, Marco; Quecchia, Cristina; Fassio, Filippo; Heffler, Enrico; Canonica, Giorgio Walter (2015-08-04). "Escaping the trap of allergic rhinitis". Clinical and Molecular Allergy. 13 (1): 17. doi:10.1186/s12948-015-0023-y. ISSN 1476-7961. PMC 4524393. PMID 26244040.
  13. ^ "Editorial introductions". Current Opinion in Allergy and Clinical Immunology. 4 (1): i. February 2004. ISSN 1528-4050.
  14. ^ "Professor G. Walter Canonica, MD | The AIT Network". www.theaitnetwork.com. Retrieved 2021-07-05.
  15. ^ Kaliner, Michael A. (2011-01-01). "History of the World Allergy Organization: Two Decades Leading to World Leadership, 1990-2010". World Allergy Organization Journal. 4 (11): 231–248. doi:10.1097/WOX.0b013e31823ba552. ISSN 1939-4551. PMC 3488903. PMID 23268440.
  16. ^ "Academy of Europe - Giorgio Walter Canonica". www.ae-info.org. Retrieved 2021-07-05.
  17. ^ "Canonica G. Walter, Professor of Respiratory Diseases and Allergy - Director". lung-health.org. Retrieved 2021-07-05.
  18. ^ Kostaras, Charalampos. "Science Committee | EAACI.org". www.eaaci.org. Retrieved 2021-07-05.
  19. ^ Canonica, Giorgio Walter (2020-11-25). "COVID-19 Pandemic Allergen specific Immunotherapy Positioning in Respiratory Allergy". US Respiratory & Pulmonary Diseases. 5: 10. doi:10.17925/USPRD.2020.5.1.10. S2CID 234941178.
  20. ^ "Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)". SANI (Severe Asthma Network Italy).

See also[edit]

Retrieved from "https://en.wikipedia.org/w/index.php?title=Giorgio_Walter_Canonica&oldid=1193912350"